IRINOTECAN HYDROCHLORIDE INJECTION USP
PFIZER CANADA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of IRINOTECAN HYDROCHLORIDE INJECTION USP in Canada?
A shortage of IRINOTECAN HYDROCHLORIDE INJECTION USP 20MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 7, 2026), but it has not started yet.
Why is IRINOTECAN HYDROCHLORIDE INJECTION USP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will IRINOTECAN HYDROCHLORIDE INJECTION USP be available again?
The manufacturer's estimated resolution date is March 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
CAMPTOSAR
PFIZER CANADA ULC
IRINOTECAN HYDROCHLORIDE TRIHYDRATE INJECTION
SANDOZ CANADA INCORPORATED
IRINOTECAN HYDROCHLORIDE INJECTION USP
ACCORD HEALTHCARE INC
IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION
FRESENIUS KABI CANADA LTD
IRINOTECAN HYDROCHLORIDE INJECTION, USP
GENERIC MEDICAL PARTNERS INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2027-03-31
~6 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02258218
Strength
20MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
IRINOTECAN HYDROCHLORIDE
Tier
Unrated
Last Updated
2026-08-07
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
IRINOTECAN HYDROCHLORIDE INJECTION USP has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
20MG · DIN 02511061
40MG · DIN 02511045
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347